MannKind and Rose Pharma ink licensing deal for inhaled GLP-1
MannKind and Rose Pharma entered a licensing and collaboration agreement to develop an inhaled rapid-acting, short-duration GLP-1 for weight management.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.